Trump DOJ Reportedly Reclassifies Marijuana, Leaving Policy Gaps for Employers
A reported move by the Trump administration to reclassify medical marijuana is raising new questions about what it means for workers and federal policy.
According to the provided report, acting attorney general Todd Blanche signed an order placing FDA-approved and state-licensed medical marijuana into Schedule III, a less restrictive category. That would mark a major shift from its long-standing classification alongside more tightly controlled substances.
Subscribe free for daily political analysis they won’t broadcast. Join 110K+ readers →
The conflict centers on how far the change actually goes. While the report frames it as a regulatory downgrade, no widely confirmed federal announcement has surfaced, leaving uncertainty about whether the move is finalized, proposed, or limited in scope.
If accurate, the shift could affect workplace drug policies, federal enforcement, and tax treatment for cannabis businesses. Workers in states with legal medical marijuana could see fewer employment conflicts, though federal protections would still depend on agency rules and employer policies.
For now, the biggest question remains whether this change is fully implemented or still in transition.
Download a FREE Pocket Constitution NOW →
